Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

This study is ongoing, but not recruiting participants.

Study NCT00954889 Information provided by Samsung Medical Center

First Received: August 5, 2009 Last Updated: October 31, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)